Literature DB >> 17187230

A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma.

Crispin R Dass1, Eugene T Ek, Karla G Contreras, Peter F Choong.   

Abstract

As a reliable model for osteosarcoma is lacking, three human cell lines (SaOS-2, U2OS and 143B) were evaluated in cell-based assays for proliferation, adhesion, migration, invasion, anchorage-independent growth, angiogenesis, mineralised nodule formation, plasmid transfection and oligonucleotide transfection. Tumor take and metastasis after orthotopic injection of the three cell lines into mice was monitored. The levels of expression of typical bone markers were determined with semi-quantitative RT-PCR in cultured cells, primary tumors, and for the SaOS-2 cell line, the metastases. Tumors grew and spread to the lungs within 3 and 5 weeks respectively, mimicking the clinical progression of the disease as analysed by x-ray. Expression of molecular markers in SaOS-2 indicated a mostly differentiated cell type at the primary and secondary sites. The ability of osteosarcoma cells to interact with collagen-1 and to form mineralised deposits correlated positively with tumor aggression in vivo. Expression of alkaline phosphatase was a common theme in both tumor models at the primary site. The newly established SaOS-2 model should allow the testing of candidate anti-osteosarcoma agents as well as dissection of more intricate mechanisms involved in human osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187230     DOI: 10.1007/s10585-006-9046-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  28 in total

1.  Cellular uptake, distribution, and stability of 10-23 deoxyribozymes.

Authors:  Crispin R Dass; Edward G Saravolac; Yang Li; Lun-Quan Sun
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2002-10

2.  Cultivation in vitro of cells derived from a human osteosarcoma.

Authors:  R M McAllister; M B Gardner; A E Greene; C Bradt; W W Nichols; B H Landing
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

3.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

4.  Two established in vitro cell lines from human mesenchymal tumours.

Authors:  J Pontén; E Saksela
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

5.  An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.

Authors:  Hue H Luu; Quan Kang; Jong Kyung Park; Weike Si; Qing Luo; Wei Jiang; Hong Yin; Anthony G Montag; Michael A Simon; Terrance D Peabody; Rex C Haydon; Carrie W Rinker-Schaeffer; Tong-Chuan He
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

6.  Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.

Authors:  Eric C McGary; Kristy Weber; Lisa Mills; Michelle Doucet; Valerie Lewis; Dina Chelouche Lev; Isaiah J Fidler; Menashe Bar-Eli
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

Review 7.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

8.  Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

Authors:  A Mizuno; N Amizuka; K Irie; A Murakami; N Fujise; T Kanno; Y Sato; N Nakagawa; H Yasuda; S Mochizuki; T Gomibuchi; K Yano; N Shima; N Washida; E Tsuda; T Morinaga; K Higashio; H Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

9.  In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo.

Authors:  H Zhou; P Choong; R McCarthy; S T Chou; T J Martin; K W Ng
Journal:  J Bone Miner Res       Date:  1994-09       Impact factor: 6.741

10.  SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

Authors:  A Mettouchi; F Cabon; N Montreau; P Vernier; G Mercier; D Blangy; H Tricoire; P Vigier; B Binétruy
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  31 in total

1.  Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases.

Authors:  Jun Yuan; Christian Ossendorf; Jan P Szatkowski; James T Bronk; Avudaiappan Maran; Michael Yaszemski; Mark E Bolander; Gobinda Sarkar; Bruno Fuchs
Journal:  Cancer Invest       Date:  2009-05       Impact factor: 2.176

2.  RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.

Authors:  Toru Akiyama; Peter F M Choong; Crispin R Dass
Journal:  Clin Exp Metastasis       Date:  2010-04-11       Impact factor: 5.150

3.  Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy.

Authors:  Xiao-zhong Zhu; Hong-mei Yin; Jiong Mei
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

4.  An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis.

Authors:  Joseph L Sottnik; Dawn L Duval; E J Ehrhart; Douglas H Thamm
Journal:  Clin Exp Metastasis       Date:  2010-03-07       Impact factor: 5.150

5.  Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.

Authors:  Zheng-Xuan Liu; Liang Hong; Song-Qing Fang; Guang-Hua Tan; Pei-Guan Huang; Zhi Zeng; Xue Xia; Xiao-Xu Wang
Journal:  Tumour Biol       Date:  2016-09-19

6.  Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials.

Authors:  Xiang Chen; Tong-Tao Yang; Wei Wang; Hong-Hui Sun; Bao-An Ma; Cun-Xiao Li; Qiong Ma; Zhe Yu; Qing-Yu Fan
Journal:  Cytotechnology       Date:  2009-11-29       Impact factor: 2.058

7.  Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.

Authors:  Yi Guo; Elyssa M Rubin; Jun Xie; Xiaolin Zi; Bang H Hoang
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

8.  Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Cell Int       Date:  2010-03-24       Impact factor: 5.722

9.  New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis.

Authors:  Jonathan Cm Clark; Toru Akiyama; Crispin R Dass; Peter Fm Choong
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

10.  Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor.

Authors:  Eugene T H Ek; Crispin R Dass; Karla G Contreras; Peter F M Choong
Journal:  Clin Exp Metastasis       Date:  2007-04-18       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.